A radiologist is reviewing requests for gadolinium-based contrast MRI (ACR Group II agent). In which of the following clinical scenarios is contrast-enhanced MRI CONTRAINDICATED or requires special caution?

Appeared in: PGIMER Chandigarh NO - 2015

Explanation

An estimated Glomerular Filtration Rate (eGFR) of 30 mL/min/1.73 m² indicates severe renal impairment (on the cusp of Stage 4 Chronic Kidney Disease).
Severe renal dysfunction is the primary risk factor for developing Nephrogenic Systemic Fibrosis (NSF), a rare but serious complication of gadolinium-based contrast agents (GBCAs).
Although the question specifies a safer ACR Group II agent, the American College of Radiology (ACR) guidelines still advise caution in patients with eGFR below 30 mL/min/1.73 m².
The impaired kidneys cannot efficiently clear the gadolinium, prolonging its circulation time and increasing the risk of toxic effects, thus making this scenario the one that requires the most caution among the choices.

Option A: A child with normal renal function can efficiently clear the gadolinium contrast, making the risk of adverse effects, including NSF, extremely low.
Option C: A healthy 30-year-old has a very low pre-test probability of having severe, undiagnosed chronic kidney disease. While obtaining renal function tests is best practice, the immediate risk is considered low.
Option D: This patient has risk factors (age over 60, diabetes) for chronic kidney disease, but their renal function is unknown. The correct action is to obtain an eGFR before administering contrast. However, this is a contraindication to proceeding without testing, not an absolute contraindication for the MRI itself. The patient in option B has a known severe impairment, which is a more direct and definite reason for caution.

Clinical Relevance

Nursing practice connection: Use the key finding related to Contraindications and precautions for using gadolinium-based contrast agents (GBCAs) in MRI to guide bedside assessment, documentation, and the next nursing action.
A nurse's primary role in pre-procedural screening for contrast-enhanced MRI is to verify patient history for risk factors like diabetes, hypertension, and known kidney disease.
Nurses must ensure that recent renal function tests (eGFR/creatinine) are available and documented for at-risk patients, as per institutional policy, before sending them for the procedure.
Patient safety is paramount. Flagging a patient with a low eGFR (e.g., 30) to the radiology department and the ordering physician is a critical safety intervention to prevent potential harm from NSF.

How to Approach the Question

Identify the core concept of the question: safety of gadolinium-based contrast agents (GBCAs).
Recognize that the primary risk associated with GBCAs is Nephrogenic Systemic Fibrosis (NSF), which is directly linked to renal function.
Understand that estimated Glomerular Filtration Rate (eGFR) is the key metric for assessing renal function and risk.
Evaluate each option based on its eGFR status. A known low eGFR (Option B) represents a definite, high-risk situation.
Compare the definite risk in Option B with the potential/unknown risks in Options C and D. A known severe condition is a more direct contraindication or reason for caution than a potential one.
Conclude that the patient with a documented eGFR of 30 mL/min/1.73 m² presents the clearest case for requiring special caution.

Concept Tested & Keywords

Concept Tested: Contraindications and precautions for using gadolinium-based contrast agents (GBCAs) in MRI.
Stem keywords: gadolinium-based contrast, MRI, ACR Group II agent, CONTRAINDICATED, special caution
Lead-in keywords: CONTRAINDICATED, requires special caution

qYQemNfj1tPqo2zCJ4hFs

E6 Medicine Harrison 22e Part 2 pp. 1293-1295, 1290-1292

Practise the full PGIMER Chandigarh NO - 2015

Attempt every question from this paper in a timed mock, then review the full solution for each one.